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Background: The intensive requirement of organs for transplantation generates the need for higher rates of donation. Methods: Using the
national database of diagnosis-related groups for 2006, the global annual 2006 in-hospital mortality of 34 hospitals with organ-retrieval
schemes was evaluated. Potential donors were estimated excluding patients aged <1 year or >70 years and presenting International
Classification of Diseases, Ninth Revision codes that contraindicated organ donation. Results: We identified 3838 potential donors (12.6%
of in-hospital deaths); 46% came from eight hospitals, 80% came from the larger hospitals and 21% from intensive care units (ICU). In
hospitals with a neurosurgical department, an office coordinator of procurement and transplantation (OCPT), a transplant centre and
co-location of neurosurgical and transplant centre, we identified, respectively, 54, 30, 32 and 30% of all potential donors. The causes of
death were 23% cerebrovascular disease, 3% cerebral tumour, 2.6% anoxic lesion and 2.5% head trauma. In the same period, there were
189 effective deceased kidney donors with traumatic diseases as the main cause of death. The mean conversion rate was 4.9% and was
associated with demographical and hospital characteristics. Age of potential donors, existence of OCPT or transplant centre, ratio between
ICU and hospital acute beds and mortality from labour accidents were predictors of being an effective donor. Conclusions: Health policies
need to maximize the conversion of potential to effective donors and the performance of organ donation systems must be considered as an
index of the quality of care.
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Introduction
In Western Europe, there are more than 40 000 patients on waiting listsfor transplantation with a mortality rate of 6.3% while waiting for a
kidney.1 Organs from extended criteria donors have increasingly been
used and, while a condemnable practice,2 organ trafficking, transplant
commercialization and transplant tourism area are a reality today.
Portugal, a country with 10.6 million inhabitants, has an annual
incidence of 234 per million population (pmp), a prevalence of 1600
pmp of chronic kidney disease (CKD) stage 5d; 2500 people are
waiting for a kidney transplant (Portuguese Society of Nephrology,
2009). Contributing causes are ageing (17.6% population aged 65
years), high prevalence of arterial hypertension (42%)3 and of diabetes
mellitus type 2 (12.4%).4 The rate of donation has been increasing,
reaching 31 pmp in 2009, placing Portugal in second place in the
world. In 2009, 563 renal transplants (53 ppm) were performed. The
definition and the methodology for assessment of brain death are
legislated. Since 1994, Portugal has a presumed consent system
supported on a national registry of refusal to organ donation
(RENNDA). By the end of 2008, there were 37 461 people registered as
no donors (0.35% of population). Families of deceased donors are
approached as negative public opinion may be harmful for organ
donation. The rate of refusal is 6%.1 There are five office coordinator
of procurement and transplantation (OCPT) located in central hospitals,
two in the North, one in the Centre and two in the South of the country;
each one is articulated with a group of hospitals that meet the legal
requirements for recovery of organs. These OCPTs were integrated in
the Portuguese Organization of Transplantation (OPT) and, since May
2007, in the Authority for Blood and Transplantation Services (ASST).
The evaluation of potential donors at national level is needed to assess
fairly the performance of individual Organ Procurement Organization
(OPO) and of the organizational network as a whole.5 Some authors
argue that the ratio between effective and potential donors is a better
metric than effective donors ppm because it is independent of population
characteristics6 and enables comparison of performance of OPOs among
countries.7
This study aims to assess the number, characteristics and causes of
death of potential donors compared with effective donors. It will seek
to identify the individual, hospital and demographical factors associated
with the conversion rate for the year 2006.
Methods
Data sources: hospital data, including the diagnosis-related groups
(DRG) 2006 database, were obtained from the Ministry of Health,
Central Administration of Health System (ACSS). This entity centralizes
the data of all hospital cases in public hospitals which are classified by a
trained physician into one of DRGs based on International Classification
of Diseases, Ninth Revision (ICD-9 CM) diagnoses. Demographical data
were obtained from the National Institute of Statistics. Recovery hospitals
were identified from the Report of OPT 2005–06. The characteristics of
effective donors, and organs not usable by the teams of organ recovery or
not accepted by transplant centres were provided by ASST. The authors
used the last available reports of ACSS and OPT and no significant al-
terations were introduced in the deceased organ procurement
programme since the data were collected.
A retrospective study was conducted to analyze mortality in the 34
hospitals with organ recovery. Potential donors were defined as
patients aged >1 year and <70 years, died in hospital and deemed
medically suitable for organ donation.8
Two lists were set up, one with the hospitals with organ recovery and
another with the exclusion criteria: infectious and neoplastic diseases,
diabetes mellitus type 1, renal chronic disease and risk behaviours.
In the national DRG database, the data of all hospitalizations were
selected using three criteria: code of destination = death; age 1 and
70 years and hospital with organ recovery, generating a list of
possible donors. Then, the ICD-9-CM codes that contraindicate
donation were checked in all diagnoses (maximum possible: 20) that
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classify each episode of hospitalization, generating the potential donors.
The distribution by cause of death: cerebrovascular diseases (CVA), head
trauma, brain tumour and anoxia were analysed.
A second database was constructed considering each hospital as a unit
of observation to assess the factors affecting the number of potential
donors and the conversion rate defined as the ratio between the
number of effective donors and potential donors, and used as a proxy
for each hospital’s donor efficiency.
Selected characteristics of the hospitals were central vs. district
hospitals; number of health professionals; number of intensive care
units (ICUs) beds; acute beds stratified by number: <150, 150–350 and
>350; the case-mix index (a measure of the costliness and complexity of
cases treated by a hospital); existence of neurosurgical department, OCPT
or transplant centre. Demographical data included an ageing index
(number of residents aged 65 years/100 residents <15 years); a mascu-
linity index (number of males/100 females); population density;
number of physicians and nurses/100 000 population; mortality rates
from cardiovascular and neoplastic diseases, and road and labour
accidents.
The performance of OPOs was evaluated by the conversion rate and
the potential donors/pmp stratified at national, regional and OCPT level.
Statistical analysis
Descriptive statistics were computed for all variables. Results are
expressed as arithmetic mean and 95% confidence intervals for
normally distributed samples, or median with percentiles 25–75 for
skewed variables. Student’s t-tests or analysis of variance were used to
compare the means between samples or their non-parametric equivalents.
Pearson correlation or its non-parametric equivalent
Spearmancorrelation coefficients were used to measure the association
between continuous variables. Chi-squared test was used to test for as-
sociations between discrete variables. We used logit regression for
grouped data to investigate the relationship between becoming an
effective donor and several independent predictor variables. Statistical
significance was assumed for P < 0.05. Statistical analysis was performed
with SPSS, version 13.0. Logit regression was carried out using STATA,
version 8.
Results
In the 34 hospitals analysed, there were 30 488 deaths, corresponding to
70% of all in-hospital deaths in Portugal in 2006. For patients aged 1–70
years, there were 9752 deaths; 5914 of which had ICD-9-CM codes that
contraindicated organ donation. In two hospitals, no deceased donor met
the inclusion criteria. We identified 3838 potential donors from 32
hospitals, corresponding to 0.5% of the episodes of hospitalization and
12.6% of all in-hospital deaths. Demographical and hospital characteris-
tics are given in table 1.
The median number of potential donors per hospital was 102.5
(percentile 25–75: 65–176). We identified 1801 potential donors (46%
of total) in eight hospitals, of whom 536 were admitted to ICUs (65% of
all ICU admissions).
Applying to 3838 potential donors the ICD-9 CM codes representing
the pathologies that often evolve to brain death,9 we identified 608
deaths. This subgroup of potential donors will be called realistic
potential donors. A diagram is shown in figure 1.
In hospitals with neurosurgical department, OCPT, transplant centre
and co-location of neurosurgical department and transplant centre, we
identified, respectively, 2090 (54%), 1173 (30%), 1221 (32%) and 1147
(30%) of potential donors.
The number of potential donors correlates with the following hospital
characteristics:
 Number of nurses (r = 0.807; P < 0.001)
 Number of acute beds (r = 0.806; P < 0.001)
 Number of physicians (r = 0.768; P < 0.001)
 Number of ICU beds (r = 0.740; P < 0.001)
No correlation was found with ageing index, traffic accident and rates
of mortality from cardiovascular and neoplasic diseases.
In 2006, there were 189 effective kidney donors, mainly male (65%),
with a median age of 44 years (percentiles 25–75: 28.5–56). Four kidneys
were considered unusable by the recovery teams, eight kidneys were
refused by the transplant centres, and so 366 kidney grafts were
implanted.
The number of potential donors correlates with the number of effective
donors (r = 0.626; P < 0.001).
In effective donors, the cause of death differs with age (2 = 35.267;
P < 0.001) and sex (2 = 15.483; P < 0.001).
The mean of the conversion rate was 4.9%. The conversion rate directly
related with (i) the number of physicians (r = 0.501; P < 0.01) and nurses
per 100 000 population (r = 0.499; P < 0.01), (ii) the absolute number of
hospital physicians (r = 0.464; P < 0.01), (iii) the number of beds in ICUs
(r = 0.464; P < 0.01)), (iv) the ratio between ICUs and acute beds in each
hospital (r = 0.496; P < 0.01) and (v) population density (r = 0.392;
P < 0.05). The conversion rate inversely related with the age of
potential donors (r =0.641; P < 0.001) and the index of masculinity
(r =0.500; P < 0.01).
The causes of death among effective and potential donors influenced
the conversion rate (table 2).
Logit regression revealed that ICU/acute beds of hospital, age, existence
of transplant centre, existence of OCPT and mortality from labour
accidents in the areas of the hospitals were significant predictors for a
potential donor becoming an effective donor.
Logit estimates were used to generate predicted values for a poten-
tial donor becoming an effective donor. There was a mean of 6.13
effective donors in all hospitals; the presence of OCPT determines an
increase of this value to 12.11 and the inexistence of OCPT a decrease
to 2.80.
The distribution of the potential donors and the performance of OPOs
are shown in table 3.
Discussion
The increasing demand for organs for transplantation is in stark contrast
with their scarce supply. The dearth of deceased organs requires strategies
to optimize the performance of OPOs and to maximize the conversion of
potential into effective donors.
To our knowledge, this is the first study that evaluates the availability
of deceased kidney donors in Portugal and identifies the variables
associated with organ donation contributing to optimization of the
donation system.
Our methodology for estimating the deceased donors in Portugal differs
from previous studies from other countries.5,6,10 Their assessment has been
based on a review of medical records or on mortality rates of hospitals or
ICUs.5,11 In this study, we first identified a theoretical maximum of 3838
kidney deceased donors (patients aged 1–70 years, died in hospital,
medically suitable for kidney donation). To avoid the bias of overesti-
mating the number of potential donors, we identified 608 realistic
potential donors which corroborates the observation that less then 3%
of the in-hospital deaths have a brain death diagnosis.1 If all these patients
were admitted to ICUs, excluding the 10% who have haemodynamic in-
stability,9 we would get 548 effective donors corresponding to 54 ppm.
Table 1 Demographical and hospital-related characteristics of potential
donors
Number of potential donors 3838
Male gender (%) 2554 (66.5)
Age (years)
Male Median 60 (percentile 25–75: 50–66)*
Female Median 62 (percentile 25–75: 51–67)
Hospitalization in an ICU (%) 822 (21)
Hospitals with acute beds >350 3076 (80%)
*P<0.01 vs. female
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Larger and central hospitals have, on average, more potential donors
than smaller and district hospitals. Consequently, the number of health
professionals and ICU beds were significantly associated with the number
of potential donors. In hospitals with >350 beds, we identified 80% of
potential donors well above the 38% reported by other authors.12 The
observed 16% of potential donors in hospitals with 150–350 beds and 4%
in hospitals with <150 beds should also be kept in mind as a considerable
pool.
Like other authors, we found association between the pools of potential
donors and the number of acute and ICU beds and the presence of
specialized services.6,13 The data also indicate the effectiveness of donor
identification in these large, highly differentiated hospitals and supports
the validity of our methodology.
The lack of association between demographical characteristics and
potential donors corroborates that the hospital mortality is a more
accurate predictor of donor rates than population-specific mortality.13
Considering the presumed consent system, the low rate of refusal by
families and the small percentage of non-donors, one would expect a
higher conversion rate in Portugal. Studies about the impact of
presumed consent system on the donor rates have shown conflicting
results.14,15 A study about European countries evidenced no positive
effect7 of presumed consent suggesting that this legislation alone
will not ensure an increase of the supply of organs.15 Policy
should take into account the process of organ procurement as this
study showed.
In the hospitals with at least one organ recovered, the rate of conversion
rises from 4.9% to 6.2%, and rises to 21.5% in the two paediatric
hospitals. It seems that the act of donation is driven by a joint effort of
parents and health professionals to save the lives of other children.
Awareness of society to organ donation will extend the benefits of this
act of solidarity to all age groups. The predictors of becoming an effective
donor were presence of OCPT or transplant centre, critical/hospital acute
beds, age and mortality from labour accidents after controlling for other
variables. The association between OCPT and rate of conversion points to
the reorganization of procurement coordinators. On average, 12 potential
Figure 1 Methodological approach to in-hospital deaths audited
Table 2 Causes of death of potential and effective donors
Causes of death Potential
donors,
n (%)
Effective
donors,
n (%)
Conversion
rate,
n (%)
Head trauma 95 (2.5) 88 (46.6) 93
CVA 886 (23) 82 (43.4) 9.3
Haemorragic stroke 436 (11) 78 (41.3) 18
Ischaemic stroke 450 (12) 4 (2.1) 8.9
Brain tumour 123 (3) 2 (1.1) 1.6
Anoxia 102 (2.6) 4 (2.1) 3.9
All other causes of death 2632 (68) 13 (6.9) 0.49
Total 3838 (100) 189 (100) 4.9
Table 3 Distribution of potential donors by country region
Country region Hospitals Potential
donors
Potential
donors/million
people
Conversion
rate (%)
North 9 1171 300413 4.44
Centre 10 964 376 68 5.6
South 13 1703 402 07 4.87
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donors in hospitals with an OCPT were converted to effective donors
compared with two in hospitals without OCPT.
The association between the number of potential and effective donors
points out that the hospitals with larger number of potential donors
perform more transplants. However, we found a rate of conversion
below percentile 25 in one of the hospitals with OCPT, and below
percentile 5 in one of the hospitals with a transplant centre, suggesting
that some hospitals could improve their performance.
In Portugal, the number of critical beds is 70.7/pmp (data reported by
health authorities), whereas in Spain, the world leader of donation rates is
66.3 pmp.16 We must understand why the number of ICU beds in
Portugal is not used as leverage. The clinical situation influences
admission to ICUs. The evaluation of the performance of ICUs should
be based on an algorithm. The number of effective donors as a percentage
of potential donors must have a weighting greater than the mortality rate
so that it does not overlap the decision for non-admission in cases of
irreversibility of the clinical status of patients. The lack of resources can
lead to loss of donors because the organ donation process in ICUs is
labour intensive.17 The correlation between the numbers of potential
donors and health professionals suggests the need of on-call work
schedules. The health personnel will be available to be physically
present whenever there is a potential donor.
The existence of transplant centre was a significant predictor reflecting
the awareness for organ donation. It is accepted that young people who
die of head trauma are the main source of deceased donors, neglecting the
victims of CVA. This means an opportunity for changing this prevailing
mentality and to assume a new attitude towards organ donation. Health
professionals of the different hospital services should attend training
courses that foster a culture where each group feels that its role in the
donation process is important, creating enthusiasm and motivation to
increase the rates of transplantation.
The mortality from labour accidents was a significant predictor of
becoming an effective donor. The main cause of death in effective
donors was cranioencephalic trauma, whereas in potential donors it
was CVA. This explains the difference in the age and sex profiles
between effective and potential donors; the victims of trauma were, on
average, younger than patients with the diagnosis of CVA, and head
trauma was much more common in males than in females; moreover,
haemorrhagic stroke was equally frequent in both sexes.
As a retrospective study, the establishment of cause–effect relationship
is limited. The non-validation through a review of clinical files may be
considered another limitation.18 However, the comprehensive review of
the individual clinical registries requires a consistent patient documenta-
tion, a reliable review protocol and a high consumption of resources.10,11
At national level, it would be an insurmountable task. The audit of cases
of brain death in ICUs are conditioned by the policies of admission and
may not reflect the true incidence of potential donors.19
The international comparability of the studies is limited by the
non-uniformity of classification criteria of hospital deaths, the contra-
indications for donation and the definition of donor.11 We used
the criteria recommended by the Council of Europe and adopted by
ASST.
The high correlation between the national mortality rates of CVA
among people aged <65 years and donation rates13 may explain why
we found a large pool of potential donors and a low-conversion rate.
Worldwide there has been a change in the demographics of organ
donors with a growing percentage of non-traumatic deaths as traffic
and labour accidents decrease.10 This new paradigm should induce the
health-care organizations to recognize the individuals with brain death
resulting from non-traumatic disease as potential donors. This issue is
critical to improve organ donation rates in all countries, mostly in
Portugal, where the rate of mortality from CVA for people of both
sexes aged 25–64 years is about twice the EU 27 average.20
‘Old-for-old’ deceased transplantation has been argued as an alterna-
tive to increase the supply of organs.21 Due to socio-demographic
changes, the average age of incident patients with CKD stage 5 is 65
years.22 implying that the use of organs from victims of non-traumatic
illnesses will be common practice rather than an alternative strategy.
The benefits achieved by patients submitted to kidney transplantation
exceed those for patients on dialysis.23–25 Health authorities should
consider organ donation as a priority area of health care, providing
financial sustainability to hospitals with donation programmes. The
accountability of hospitals should be assured by considering organ
donation as a core activity and a measure of effectiveness of their
performance.26
In Portugal, considering the incidence of CKD stage 5 and annual
increase of 30% of patients waiting transplantation, the supply of
kidney is insufficient. Some authors argue for encouraging living
donation as post–mortem organ donation will not be enough.7 In
Portugal, legal requirements to living unrelated donor had been
recently introduced. The option for the widespread use of living donors
may raise ethical questions while the capacity of deceased donors is not
exhausted.
Today, budget constraints conditioned the provision of health-care
services, but as shown by several studies, the investment in organ pro-
curement saves lives and is good value for money.27–31 Increasing organ
availability will have a positive impact on social welfare.
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Key points
 This study shows that in Portugal, as in many countries, the
maximum capacity for identification and recovery of organs
from deceased donors has not been reached. Whereas an ethical
perspective, we have the right to expand the living donor
programme if the pool of deceased donors has not yet been
exhausted.
 The methodology used to evaluate the availability of deceased
donors on national level can be applied by authors of other
countries, allowing the results to be compared.
 By the identification of factors that influence the identification
and recovery of organs from deceased donors, this study contrib-
utes to the definition and implementation of strategies to increase
the rates of transplantation and to guide resource allocation to
programmes for organ donation.
 The criteria for assessing the performance of ICU should include
the number of effective donors as a percentage of potential
donors that ought to have a weight higher than other criterion,
such as mortality rates.
 The performance of organ procurement organizations, measured
by the rate of conversion of potential donors into effective
donors, should be considered an index of quality of care
provided by hospitals where there are programmes for organ
donation, assessing the effectiveness of these hospitals.
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